Important Reminder for MoonLake Shareholders from Pomerantz LLP

Pomerantz LLP wants to remind shareholders of MoonLake Immunotherapeutics about the ongoing class action lawsuit against the company (MLTX). Shareholders who purchased or acquired MoonLake securities between February 1, 2021, and November 15, 2021, are encouraged to participate in the lawsuit.

The lawsuit alleges that MoonLake made misleading statements regarding the company’s business, operational, and compliance policies. Specifically, the company failed to disclose that their lead product candidate faced significant regulatory and competitive risks, as well as other relevant issues that could impact its success.

Despite MoonLake’s positive statements, the company’s stock price experienced significant declines once the truth about these undisclosed issues came to light. Shareholders who suffered losses as a result of investing in MoonLake during the specified period may be eligible to participate in the class action lawsuit.

MoonLake shareholders are advised to contact Pomerantz LLP as soon as possible to learn more about their legal rights and options regarding the class action lawsuit. It is crucial for shareholders to act promptly to ensure they do not miss out on potential compensation for their losses.

Investing in securities always carries risks, and it is essential for shareholders to stay informed about the companies in which they invest. By participating in class action lawsuits like the one against MoonLake Immunotherapeutics, shareholders can hold companies accountable for any misleading information provided to investors.

In conclusion, Pomerantz LLP is reminding MoonLake Immunotherapeutics shareholders of the ongoing class action lawsuit against the company. Shareholders who purchased or acquired MoonLake securities between February 1, 2021, and November 15, 2021, may be eligible to participate in the lawsuit. It is crucial for shareholders to take action promptly to protect their legal rights and potentially recover losses incurred during the specified period.